ORENCIA BELATACEPT ANALOG COMBINED REGIMEN

The emerging treatment approach of abatacept, a T-cell modulator, and a CTLA4 immunoglobulin (CTLA4lg) represents a significant route for managing immune-mediated diseases. This distinct approach intends to enhance immune suppression by inhibiting co-stimulatory signals vital for T-cell activatio